Thursday, September 12, 2024
9/12/2024
Project Title: The National Cardiovascular Health Program (CDC-RFA-DP-23-0004) Applicant Organization: Idaho Department of Health and Welfare Physical Location: 450 West State Street Boise, Idaho 83702 State Served: Idaho Project Director: Angie Bailey, RDH-EA, MSDH, Section Manager, Chronic Disease Section, Bureau of Community Health, Division of Public Health, Idaho Department of Health & Welfare Phone Number: 208-334-6605 Email Address: Angie.Bailey@dhw.idaho.gov Website: https://healthandwelfare.idaho.gov Funds Requested: $925,161 The purpose of this application is to advance Idaho’s cardiovascular disease (CVD) prevention and management infrastructure to reduce health disparities for Idaho’s priority populations as identified by the Idaho Cardiovascular Health Learning Collaborative. All work proposed in this application will support increasing patient identification and referrals to both community resources and evidence-based interventions for the prevention and management of CVD supported by key partnerships with organizations primarily serving priority populations. The Idaho Diabetes, Heart Disease, and Stroke Prevention (DHDSP) Program within the Idaho Department of Health and Welfare maintains the ability to serve all populations and communities, statewide. Through new and longstanding partnerships, the Idaho DHDSP Program will expand evidence-based services to improve access for priority populations in CVD management and social support services. System and population-level needs related to social determinants of health will be addressed to support priority population engagement in the selected strategies. The Idaho DHDSP Program will work toward achieving the following outcomes: • Increased use of EHRs or HIT to report, monitor, and track clinical and social services and support needs data to improve detection of health care disparities and the identification, management, and treatment of patients at highest risk of cardiovascular disease, with a focus on hypertension and high cholesterol. • Increased use of standardized processes or tools to identify, assess, track, and address the social services and support needs of patient populations at highest risk of CVD. • Increased use of EHRs or HIT to support communication and coordination among care team members to monitor and address patients’ hypertension and high cholesterol. • Increased use of multidisciplinary care teams adhering to evidence-based guidelines to address patients' social services and support needs and improve the management and treatment of hypertension and high cholesterol. • Increased multidisciplinary partnerships that address identified barriers to social services and support needs within populations at highest risk of CVD. • Increased community clinical links to identify and respond to social services and support needs of populations at highest risk of CVD with a focus on hypertension and high cholesterol. • Increased engagement of CHWs (or their equivalents) to provide a continuum of care extending clinical interventions and addressing social services and support needs. • Increased use of SMBP with clinical support within populations at highest risk of hypertension. • Improved blood pressure control among populations within partner health care and community settings. • Reduced disparities in hypertension control among populations within partner health care and community settings. • Increased utilization of social services and support among populations at highest risk of CVD, with a focus on hypertension and high cholesterol.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
